Enfermedades emergentes y reemergentes en Yucatán a finales del ...

264
RA Góngora-Biachi, CJ Castro-Sansores, H Pérez-Carrillo y col.
4.- Linnen J, Wages J Jr, Zhang-Keck ZY, et al. Molecular
cloning and disease association of hepatitis G virus: a
transfusion-transmissible agent. Science 1996; 271:505-
509.
5.- Schlauder GG, Dawson GJ, Simons JN, et al. Molecular
and serologic analysis in the transmission of the GB hepatitis
agents. J Med Virol 1995; 46:81-90.
6.- Alter HJ. The cloning and clinical implication of HGV
and HGBV-C. N Engl J Med 1996; 334:1536-37.
7.- Masuko, K, Mitsui T, Iwano K, et al. Infection with
hepatitis GB virus C in patients on maintenance
hemodialysis. N Engl J Med 1996; 334:1485-90.
8.- Góngora-Biachi RA, González-Martínez P, Puerto FI,
Yamaguchi K, Nishimura Y, Takatsuki K. Antibodies to
hepatitis C virus in people from Yucatan Mexico. Rev Inv
Clin 1992; 44:284.
9.- Marvis LM, Davidson F, Hanley JP, Yap PL, Ludlam
CA, Simmonds P. Infection with hepatitis G virus among
recipients of plasma products. Lancet 1996; 348:1352-55.
10.- Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection
in drug abusers with chronic hepatitis C. N Engl J Med
1996; 334:195-196.
11.- Tanaka E, Alter HJ, Nakatsuji Y, et al. Effect of hepatitis
G virus infection on chronic hepatitis C. Ann Intern
Med 1996; 125:740-743.
EHRLICHIOSIS.
1.- Schaffner W, Standaert S.M. Erlichiosis. In pursuit of
an emerging infection. N Engl J Med 1996; 334:262-63.
2.- Mc. Dade JE. Ehrlichiosis-A disease of animal and
human. J Infect Dis 1990; 161:609-17.
3.- Dumler JS, Bakken JS. Ehrlichial diseases of human:
Emerging tick-borne infection. Clin Infect Dis 1995;
20:1102-1110.
4.- Góngora-Biachi RA, Castro-Sansores C, González-
Martínez P, Zavala-Velázquez J. Erlichiosis: una enfermedad
emergente de interés hematológico. En: Memorias
XXXVIII Jornada Anual Agrupación Mexicana para el
Estudio de Hematología, A.C. León: AMEH, A.C. 1997:42.
5.- Walker HD, Dumler JS. Emergence of the Ehrlichiosis
as human health problems. Emerging Infect Dis 1996; 2:18-
29.
Revista Biomédica
6.- Dawson JE, Fishbein DB, Eng TR, Redus MA, Greene
NR. Diagnossis of human Ehrlichiosis with the indirect
fluorescent antibody test: Kinetics and especificity. J Infect
Dis 1990; 162:91-95.
7.- Goodman JL, Nelson C, Vitale B, et al. Direct cultivation
of the causative agent of human granulocytic ehrlichiosis.
N Engl J Med 1996; 334:209-215.
LA RELACIÓN ENTRE LAS ENFERMEDADES PSI-
QUIÁTRICAS Y EL VIRUS DE LA ENFERMEDAD
DE BORNA.
1.- Kaplan HI, Sadock BJ, Grebb JA. En: Mood Disorders.
Synopsis of psichiatry: Behaviroral science clinical
psiquiatry. 7º edition, Baltimore: Williams & Wilkins.
1994:516-572.
2.- Editorial. Current concepts in schizophrenia:
International symposia report new standards for assessment
and treatment. Part I: Patholophysiology research prompts
assessment updates. J Clin Psychiatry 1995; 56:214-225.
3.- http://cenids.ssa.gob.mx/new/mortalidad.html
4.- Nakamura Y, Kishi M, Nakaya T, et al. Demonstration
of Borna Disease Virus RNA in peripherical blood
mononuclear cells from healthy horses in Japan. Vaccine
1995; 13:1076-1079.
5.- de la Torre JC. Molecular biology of Borna disease virus:
Prototype of a new group of animal virus. J Virol 1994;
68:7669-7675.
6.- Briese T, Schneemann, Lewis AJ, et al. Genomic
organization of Borna disease virus. Proc Natl Acad Sci
USA 1994: 91:4362-4366.
7.- Pini P. Firts isolation of Borna disease virus in affective
disorder. Lancet 1996; 348:256.
8.- Waltrip RW, Buchanan RW, Summerfelt A, et al. Borna
disease virus and schizophrenia. Psychiatry Res 1995;
56:33-44.
9.- Sauder C, Müller A, Cubitt B, et al. Detection of Borna
disease virus (BDV) antibodies and BDV RNA in
psychiatric patients: Evidence for high sequence
conservation of human blood-derived BDV RNA. J Virol
1996; 70:7713-7724.
10.- Richt JA, Vande Woude S, Zink MC, et al. Infection
with Borna disease virus: Molecular and Immunobiological